Nobel Prize Recipient, Louis Ignarro, on Scientific Committee of “Fondazione Internazionale Menarini”

FLORENCE, Italy, Oct. 24, 2019 /PRNewswire/ — His discoveries have changed the lives of millions of people. Thanks to his insight, he has won the world’s most prestigious scientific honour. Today, his valuable experience will contribute towards bolstering the mission of the “Fondazione Internazionale Menarini” which welcomes the winner of the Nobel prize for Medicine, Louis Ignarro.

Born in Brooklyn (New York), the son of Italian immigrants, Ignarro discovered his love for chemistry at the age of 8 when he carried out his first experiments with a children’s game. This passion never faded and, after a brilliant academic career at the Columbia University in New York and long periods of research in other prestigious American universities, he joined the University of California, Los Angeles (UCLA). It was during this time that he was awarded the Nobel Prize for Medicine and Physiology “for his contribution in discovering the workings of the nitric acid molecule in the cardiovascular system.” It is to his studies that we owe the development of medicines commonly used in treating erectile dysfunction and hypertension. Ignarro is one of the founders of the Nitric Oxide Society and is currently Professor of Pharmacology in the Department of Molecular Medical Pharmacology at the UCLA School of Medicine.

Speaking from Los Angeles, Louis Ignarro, had this to say about this exciting collaboration with the Foundation: “Having taught in several American universities, I have always appreciated the work carried out by the Fondazione Internazionale Menarini: their educational activities at congresses and on the internet represent a unique scientific asset. Thanks to this collaboration, I shall continue to contribute to the scientific instruction of researchers, clinicians, students, and young people.”

“We are honoured to have Professor Ignarro join our Scientific Committee,” commented Lorenzo Melani, Chairman and Scientific Director of the Fondazione Internazionale Menarini. “With the help of his experience, we shall continue to further promote research and understanding in the fields of biology, pharmacology, medicine, economics, and human sciences, which represent the institutional aims of the Fondazione Internazionale Menarini.”

For further information on “Fondazione Internazionale Menarini” visit the website https://www.en.fondazione-menarini.it/.

Photo – https://healthtechnologynet.com/wp-content/uploads/2019/10/Louis_Ignarro.jpg
Logo – https://healthtechnologynet.com/wp-content/uploads/2019/10/Menarini_Logo.jpg

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/nobel-prize-recipient-louis-ignarro-on-scientific-committee-of-fondazione-internazionale-menarini-300945011.html

SOURCE Menarini I.F.R.

Staff

Recent Posts

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI)…

2 hours ago

Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship

The New Year Introduces Continuum's Entry-Level Tier, Starting at $25,000 Per YearNEW YORK, Dec. 22,…

5 hours ago

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with…

5 hours ago

KLAS Report Shows Strong Early Results for TrustCommerce Cloud Payments

CHICAGO, Dec. 22, 2025 /PRNewswire/ -- TrustCommerce®, a Sphere company and leading provider of end-to-end…

5 hours ago

BioFlorida Announces Appointment of Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of the Southeast Chapter

MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is…

5 hours ago

Truemed Closes $34 Million Series A To Unlock HSA/FSA Funds For Lifestyle Interventions

Andreessen Horowitz leads the funding round which will accelerate the company's leadingtelehealth marketplaceAUSTIN, Texas, Dec.…

5 hours ago